18:03 · 11 May 2026 Medicare's Alzheimer's Drug Spending Projection Far Exceeds Reality Medicare's initial cost estimate for the Alzheimer's drug Leqembi was $3.5 billion for 2025, but new data shows this projection was significantly over...